A Study of the Long-Term Safety of Crisaborole Ointment, 2% in Japanese Pediatric and Adult Participants With Mild to Moderate Atopic Dermatitis

Summary

This study is a Phase 3, multicenter, open-label, long-term safety extension study of Studies C3291032 and C3291031 in Japanese pediatric and adult participants with mild to moderate Atopic Dermatitis (AD).

Timeline

Start

2020-09-14

Primary completion

2020-12-18

Completion

2020-12-18

Outcome

Outcome not reported

Stopped (Business): “Terminated (This decision was made for business reasons only and is not related to any safety concerns regarding crisaborole.)”

Drugs

Indications